相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent Advances of CRISPR/Cas9-Based Genetic Engineering and Transcriptional Regulation in Industrial Biology
Shangjie Zhang et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
Prasanta K. Dash et al.
NATURE COMMUNICATIONS (2019)
Current Status of Gene Therapy in Hepatocellular Carcinoma
Saranya Chidambaranathan Reghupaty et al.
CANCERS (2019)
CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway
Shuhua Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Inducing and exploiting vulnerabilities for the treatment of liver cancer
Cun Wang et al.
NATURE (2019)
Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
Lai Wei et al.
NATURE COMMUNICATIONS (2019)
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Joong-Won Park et al.
KOREAN JOURNAL OF RADIOLOGY (2019)
CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool
Alexandre Loureiro et al.
ANTIBIOTICS-BASEL (2019)
Thermo-triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy
Peng Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma
Yijie Ma et al.
GENE (2018)
CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells
Jia Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
CRISPR/Cas9Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development
Arinze Okoli et al.
VIRUSES-BASEL (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
Johnny H. Hu et al.
NATURE (2018)
Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
Xingliang Guo et al.
FRONTIERS IN PHARMACOLOGY (2018)
CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
Xiaojuan Liu et al.
CELL RESEARCH (2017)
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice
Chun-Qing Song et al.
GASTROENTEROLOGY (2017)
CRISPR/Cas9: at the cutting edge of hepatology
Francis P. Pankowicz et al.
GUT (2017)
New development in CAR-T cell therapy
Zhenguang Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline
Lars Aabakken et al.
JOURNAL OF HEPATOLOGY (2017)
Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene
Zhang-Hui Chen et al.
NATURE BIOTECHNOLOGY (2017)
Hepatitis B Surface Antigen Promotes the Invasion of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells by Upregulation of Toll-Like Receptor 2
Shan Cheng et al.
VIRAL IMMUNOLOGY (2017)
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
Eunji Kim et al.
NATURE COMMUNICATIONS (2017)
Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Nader N. Massarweh et al.
CANCER CONTROL (2017)
Cancer immunotherapies targeting the PD-1 signaling pathway
Yoshiko Iwai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Systematic Review and Meta-Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma
Jing-Tao Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering
Addison V. Wright et al.
CELL (2016)
Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA
Christoph Seeger et al.
MOLECULAR THERAPY (2016)
CRISPR gene editing tested in a person
David Cyranoski
NATURE (2016)
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Alexis C. Komor et al.
NATURE (2016)
CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes
Bastiaan Evers et al.
NATURE BIOTECHNOLOGY (2016)
Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells
Daesik Kim et al.
NATURE BIOTECHNOLOGY (2016)
Increasing the efficiency of CRISPR/Cas9-mediated precise genome editing in rats by inhibiting NHEJ and using Cas9 protein
Yuanwu Ma et al.
RNA BIOLOGY (2016)
Continuous genetic recording with self-targeting CRISPR-Cas in human cells
Samuel D. Perli et al.
SCIENCE (2016)
Targeting hepatitis B virus cccDNA using CRISPR/Cas9
Edward M. Kennedy et al.
ANTIVIRAL RESEARCH (2015)
Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics
Ju-Tao Guo et al.
ANTIVIRAL RESEARCH (2015)
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
Chunsheng Dong et al.
ANTIVIRAL RESEARCH (2015)
Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
Sidi Chen et al.
CELL (2015)
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Bernd Zetsche et al.
CELL (2015)
Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus
S. Zhen et al.
GENE THERAPY (2015)
World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
Catherine de Martel et al.
HEPATOLOGY (2015)
Application of CRISPR/Cas9 Technology to HBV
Guigao Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome
Xing Liu et al.
JOURNAL OF GENERAL VIROLOGY (2015)
CRISPR-Cas9: a new and promising player in gene therapy
Lu Xiao-Jie et al.
JOURNAL OF MEDICAL GENETICS (2015)
CRISPR-Cas9-mediated genome editing and guide RNA design
Michael V. Wiles et al.
MAMMALIAN GENOME (2015)
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
Benjamin P. Kleinstiver et al.
NATURE (2015)
CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice
Julia Weber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
Vyas Ramanan et al.
SCIENTIFIC REPORTS (2015)
Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
Hongmei Lisa Li et al.
STEM CELL REPORTS (2015)
Generation of CRISPR/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer
Xiaoqing Zhou et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Mediated Gene Targeting in One-Cell Embryos
Yuyu Niu et al.
CELL (2014)
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases
Seung Woo Cho et al.
GENOME RESEARCH (2014)
Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac
Fei Xie et al.
GENOME RESEARCH (2014)
Cut Site Selection by the Two Nuclease Domains of the Cas9 RNA-guided Endonuclease
Hongfan Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Hepatitis B virus infection
Christian Trepo et al.
LANCET (2014)
An Efficient Antiviral Strategy for Targeting Hepatitis B Virus Genome Using Transcription Activator-Like Effector Nucleases
Jieliang Chen et al.
MOLECULAR THERAPY (2014)
High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells
Yuexin Zhou et al.
NATURE (2014)
CRISPR-mediated direct mutation of cancer genes in the mouse liver
Wen Xue et al.
NATURE (2014)
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2014)
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
David Bikard et al.
NATURE BIOTECHNOLOGY (2014)
Comprehensive analysis of the specificity of transcription activator-like effector nucleases
Alexandre Juillerat et al.
NUCLEIC ACIDS RESEARCH (2014)
Classification and evolution of type II CRISPR-Cas systems
Krzysztof Chylinski et al.
NUCLEIC ACIDS RESEARCH (2014)
AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication
Nicholas D. Weber et al.
PLOS ONE (2014)
Specific Gene Repression by CRISPRi System Transferred through Bacterial Conjugation
Weiyue Ji et al.
ACS SYNTHETIC BIOLOGY (2014)
The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
Su-Ru Lin et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
Haoyi Wang et al.
CELL (2013)
Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
F. Ann Ran et al.
CELL (2013)
Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients
Gerald Schwank et al.
CELL STEM CELL (2013)
Enhanced Efficiency of Human Pluripotent Stem Cell Genome Editing through Replacing TALENs with CRISPRs
Qiurong Ding et al.
CELL STEM CELL (2013)
Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish
Alexander Hruscha et al.
DEVELOPMENT (2013)
Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector Nucleases
Kristie Bloom et al.
MOLECULAR THERAPY (2013)
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Wenyan Jiang et al.
NATURE BIOTECHNOLOGY (2013)
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
Pablo Perez-Pinera et al.
NATURE METHODS (2013)
CRISPR interference (CRISPRi) for sequence-specific control of gene expression
Matthew H. Larson et al.
NATURE PROTOCOLS (2013)
Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system
David Bikard et al.
NUCLEIC ACIDS RESEARCH (2013)
A variant CRISPR-Cas9 system adds versatility to genome engineering
Ryan M. Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems
Krzysztof Chylinski et al.
RNA BIOLOGY (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Josiane E. Garneau et al.
NATURE (2010)
CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea
Luciano A. Marraffini et al.
NATURE REVIEWS GENETICS (2010)
Short motif sequences determine the targets of the prokaryotic CRISPR defence system
F. J. M. Mojica et al.
MICROBIOLOGY-SGM (2009)
Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
Jens Boch et al.
SCIENCE (2009)
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity
Shengyong Yin et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
CRISPR provides acquired resistance against viruses in prokaryotes
Rodolphe Barrangou et al.
SCIENCE (2007)
The PD-1-PD-L pathway in immunological tolerance
T Okazaki et al.
TRENDS IN IMMUNOLOGY (2006)
A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action
Kira S. Makarova et al.
BIOLOGY DIRECT (2006)
Prevention of hepatitis B virus-related hepatocellular carcinoma
ASF Lok
GASTROENTEROLOGY (2004)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
